Physiopathology of somatolactotroph cells: from transduction mechanisms to cotargeting therapy

Thomas Cuny1, Corinne Gerard, Alexandru Saveanu

  • 1Research Center of Neurobiology and Neurophysiology of Marseille, CRN2M, UMR 6231 CNRS, University of Mediterranée, Institut Fédératif Jean Roche, Marseille, France. thomascuny@hotmail.com

Insights

Pituitary tumors involve signaling pathways like MAP kinase. New therapies targeting these pathways, including somatostatin analogs and mTOR inhibitors, offer hope for difficult-to-treat tumors.

Area of Science:

  • Cellular signaling pathways in pituitary biology.
  • Endocrinology and neurosurgery.
  • Molecular mechanisms of pituitary tumorigenesis.

Background:

  • Pituitary somatolactotroph cells utilize signaling cascades, including MAP kinase, AC/cAMP/PKA, and PI3K/Akt pathways.
  • These pathways regulate vital functions like hormone secretion and cell proliferation.
  • Dysregulation of these signaling pathways is a primary driver of pituitary tumor development.

Purpose of the Study:

  • To explore the role of signaling pathways in pituitary tumorigenesis.
  • To identify novel therapeutic strategies for refractory GH-secreting adenomas.
  • To investigate the potential of downstream signaling inhibitors and combination therapies.

Main Methods:

  • Review of signaling cascades in pituitary cells.
  • Analysis of current treatments for GH-secreting adenomas.
  • Exploration of emerging therapeutic targets and modalities.

Main Results:

  • MAP kinase activation is a convergent point for multiple signaling pathways in pituitary cells.
  • Existing treatments like somatostatin analogs are insufficient for a subset of tumors.
  • Novel therapeutic avenues include multivalent somatostatin analogs, somatostatin-dopamine chimeric molecules, and mTOR inhibitors.

Conclusions:

  • Targeting downstream signaling pathways presents a promising therapeutic strategy for problematic pituitary tumors.
  • Combination therapies, including cotargeting and gene therapy, show potential for improved treatment outcomes.
  • Further research into novel molecular agents is crucial for managing resistant pituitary adenomas.

Related Concept Videos

Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
Secondary Active Transport01:55

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme “pump” embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
Secondary Active Transport01:32

Secondary Active Transport

One example of how cells use the energy contained in electrochemical gradients is demonstrated by glucose transport into cells. The ion vital to this process is sodium (Na+), which is typically present in higher concentrations extracellularly than in the cytosol. Such a concentration difference is due, in part, to the action of an enzyme "pump" embedded in the cellular membrane that actively expels Na+ from a cell. Importantly, as this pump contributes to the high concentration of...
Pharmacogenomics: Identification of New Drug Targets01:29

Pharmacogenomics: Identification of New Drug Targets

Advances in genomics have profoundly influenced drug discovery by increasing both the speed and accuracy of pharmaceutical development. Pharmacogenomics, which examines how genetic variation influences drug response, facilitates the identification of novel therapeutic targets and enables patient stratification for personalized treatment. These strategies contribute to improved drug efficacy, minimized adverse effects, and more efficient clinical trial design.Mapping genetic differences...
Target Cell Response to Hormones01:22

Target Cell Response to Hormones

Hormones intricately bind to receptors on the surface or within target cells, initiating a cascade of cellular responses.
Notably, the cellular response can be regulated by altering the number of receptors expressed in the cell. For example, prolonged exposure to elevated hormone levels results in a gradual decline or down-regulation in the number of receptors for that specific hormone on the cell surface. Conversely, in response to low hormone levels, cells may use up-regulation, producing an...
Signal Transduction: Overview01:26

Signal Transduction: Overview

Cells respond to many types of information, often through receptor proteins positioned on the membrane. They respond to chemical signals, such as hormones, neurotransmitters, and other signaling molecules, initiating a series of molecular reactions to produce an appropriate response. This is called signal transduction. Cells also coordinate different responses elicited by the same signaling molecule via mediators, allowing molecular cross-talk.
Typically, signal transduction involves three...